Skip to main content
Fig. 4 | Biomarker Research

Fig. 4

From: Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis

Fig. 4

Representative sequential MRI images for one patient. The images show pre-treatment liver tumor, a and macrovascular tumor thrombi b as well as post-systemic therapy liver tumor c and macrovascular tumor thrombi d. H&E staining of resected tumor samples revealed a residual HCC area accounting for around 40% of tumor volume, and infiltration of a large number of inflammatory cells into the interstitium, ×200 e, complete necrosis of the macrovascular tumor thrombi with massive inflammatory cell infiltration and areas of necrosis, × 200 f and residual hepatocellular carcinoma, ×40 g

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us